Breaking News Instant updates and real-time market news.

HAIN

Hain Celestial

$17.01

0.2 (1.19%)

06:46
12/19/18
12/19
06:46
12/19/18
06:46

Hain Celestial price target lowered to $18 from $24 at Loop Capital

Loop Capital analyst Andrew Wolf lowered his price target on Hain Celestial to $18 and kept his Hold rating following its recent event to introduce the new CEO, Mark Schiller. The analyst notes that Schiller brings an "impressive" track record of a turnaround in food companies through a bottom up approach that "builds value across the brand portfolio". However, Wolf adds that the event's discussion also illuminated the extend of the "unknown at Hain", especially in identifying which brands will be the value creators for the enterprise. While Wolf has a positive impression regarding the fit of the new CEO for the needs of the company, he remains concerned about its lack of visibility.

HAIN Hain Celestial
$17.01

0.2 (1.19%)

12/17/18
BMOC
12/17/18
NO CHANGE
Target $23
BMOC
Market Perform
Hain Celestial hinted guidance, consensus may be too high, says BMO Capital
BMO Capital analyst Amit Sharma said a recent sell-side lunch meeting with Hain Celestial's newly appointed CEO provided a "large serving" of what the problems are but not enough on either the potential solutions or how long a turnaround could take. Meanwhile, management hinted current FY19 EBITDA guidance, and even the current consensus estimate, "may be too high," according to Sharma, who lowered his price target on Hain shares to $23 from $25 ahead of the company's investor day. Sharma keeps a Market Perform rating on Hain.
12/17/18
MAXM
12/17/18
NO CHANGE
Target $36
MAXM
Buy
New Hain Celestial CEO the right man to turn around company, says Maxim
Maxim analyst Anthony Vendetti reiterated a Buy rating and $36 price target on Hain Celestial after attending a luncheon with new CEO Mark Schiller. In a research note to investors, Vendetti says he believes Schiller is the "right man" to turn around the company and is convinced that the board is aligned with the new CEO. Looking ahead, the analyst expects Hain to focus on streamlining its business to reduce complexity and improve efficiency and believes the company must first sell Hain Pure Protein and streamline the rest of its business.
11/12/18
LOOP
11/12/18
NO CHANGE
Target $24
LOOP
Hold
Hain Celestial price target lowered to $24 from $29 at Loop Capital
Loop Capital analyst Andrew Wolf lowered his price target on Hain Celestial to $24 after its Q1 results, saying the 36% decline in EBITDA amid "increased trade spending, higher costs, and supply disruptions was bigger than he expected". The analyst notes that the company's new CEO should start to "focus on marketing spending on the best opportunities" within its brand portfolio, but expects this to be a "multi-year process". Wolf adds that although consumption trends have showed signs of improving, he sees Hain Celestial's near-term risk-reward as "balanced", keeping his Hold rating.
11/09/18
JEFF
11/09/18
NO CHANGE
Target $45
JEFF
Buy
Hain Celestial selloff yesterday a buying opportunity, says Jefferies
Jefferies analyst Akshay Jagdale attributes the selloff yesterday in shares of Hain Celestial to investor concerns of an earnings reset in February following the CEO's strategic review, especially "in light of the significant" second half improvement needed to meet fiscal 2019 guidance. The analyst estimates the market is pricing in 20% lower earnings than what management guiding to, or fiscal 2019 earnings per share in the range of 98c-$1.13 versus guidance of $1.21-$1.38. The analyst, however, views the concerns as overblown. The market seems to be of the view that Hain cannot simultaneously grow its sales and its margins over the long-term, Jagdale tells investors in a research note. He disagrees, however, and views yesterday's selloff as a buying opportunity. The analyst keeps a Buy rating on Hain Celestial with a $45 price target.

TODAY'S FREE FLY STORIES

CSFL

CenterState Bank

$24.09

0.32 (1.35%)

07:36
01/24/19
01/24
07:36
01/24/19
07:36
Recommendations
CenterState Bank analyst commentary  »

Brean Capital says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Feb

HUBS

HubSpot

$152.02

0.36 (0.24%)

07:36
01/24/19
01/24
07:36
01/24/19
07:36
Downgrade
HubSpot rating change  »

HubSpot downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

MCHP

Microchip

$74.31

-0.9 (-1.20%)

07:36
01/24/19
01/24
07:36
01/24/19
07:36
Downgrade
Microchip rating change  »

Microchip downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

VIVO

Meridian Bioscience

$16.77

0.2 (1.21%)

07:36
01/24/19
01/24
07:36
01/24/19
07:36
Earnings
Meridian Bioscience reports Q4 EPS 20c, consensus 17c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 24

    Jan

AAXN

Axon

$48.06

-0.61 (-1.25%)

07:36
01/24/19
01/24
07:36
01/24/19
07:36
Hot Stocks
Axon receives Taser 7 orders from Florida Police Departments »

Axon received significant…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

CHCO

City Holding

$69.91

-0.09 (-0.13%)

07:35
01/24/19
01/24
07:35
01/24/19
07:35
Earnings
City Holding reports Q4 EPS 68c, consensus $1.24 »

Highlights of the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAL

American Airlines

$31.57

-1.18 (-3.60%)

07:34
01/24/19
01/24
07:34
01/24/19
07:34
Earnings
American Airlines reports Q4 adj. EPS $1.04, consensus $1.01 »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

MMYT

MakeMyTrip

$24.36

(0.00%)

07:34
01/24/19
01/24
07:34
01/24/19
07:34
Earnings
MakeMyTrip reports Q3 adjusted EPS (14c), consensus (37c) »

Reports Q3 adjusted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

EVRI

Everi Holdings

$6.94

0.04 (0.58%)

07:34
01/24/19
01/24
07:34
01/24/19
07:34
Hot Stocks
Everi Holdings extends employment agreement of President and CEO Michael Rumbolz »

Everi Holdings, announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GRUB

GrubHub

$74.46

-0.12 (-0.16%)

07:34
01/24/19
01/24
07:34
01/24/19
07:34
Recommendations
GrubHub analyst commentary  »

GrubHub price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

FANH

Fanhua

$23.74

1.22 (5.42%)

07:33
01/24/19
01/24
07:33
01/24/19
07:33
Hot Stocks
Fanhua completes extended repurchase program, reports new issuance »

Fanhua announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HBAN

Huntington Bancshares

$13.56

0.05 (0.37%)

07:33
01/24/19
01/24
07:33
01/24/19
07:33
Earnings
Huntington Bancshares sees FY19 revenue up approximately 4%-7% »

FY19 consensus $4.77B.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

WBS

Webster Financial

$54.34

0.19 (0.35%)

07:32
01/24/19
01/24
07:32
01/24/19
07:32
Earnings
Webster Financial reports Q4 EPS $1.05, consensus 98c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

BLPH

Bellerophon

$0.68

-0.2007 (-22.79%)

07:32
01/24/19
01/24
07:32
01/24/19
07:32
Initiation
Bellerophon initiated  »

Bellerophon initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

NBIX

Neurocrine

$89.22

-2.11 (-2.31%)

07:32
01/24/19
01/24
07:32
01/24/19
07:32
Downgrade
Neurocrine rating change  »

Neurocrine downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Feb

JBLU

JetBlue

$17.23

-0.13 (-0.75%)

07:32
01/24/19
01/24
07:32
01/24/19
07:32
Hot Stocks
JetBlue says executing plan to reach $2.50-$3.00 EPS by 2020 »

Says Q1 capacity focused…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

BTX

BioTime

$0.92

-0.0193 (-2.05%)

07:31
01/24/19
01/24
07:31
01/24/19
07:31
Initiation
BioTime initiated  »

BioTime initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HBAN

Huntington Bancshares

$13.56

0.05 (0.37%)

07:31
01/24/19
01/24
07:31
01/24/19
07:31
Earnings
Huntington Bancshares reports Q4 EPS 29c, consensus 33c »

Net interest margin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

AZPN

Aspen Technology

$89.08

0.22 (0.25%)

07:31
01/24/19
01/24
07:31
01/24/19
07:31
Recommendations
Aspen Technology analyst commentary  »

Aspen Technology price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SYF

Synchrony

$29.40

2.85 (10.73%)

07:30
01/24/19
01/24
07:30
01/24/19
07:30
Recommendations
Synchrony analyst commentary  »

Synchrony price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 11

    Feb

  • 03

    Mar

  • 28

    May

QSR

Restaurant Brands

$62.61

5.62 (9.86%)

07:30
01/24/19
01/24
07:30
01/24/19
07:30
Recommendations
Restaurant Brands analyst commentary  »

Restaurant Brands…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APY

Apergy

$33.20

-0.35 (-1.04%)

07:30
01/24/19
01/24
07:30
01/24/19
07:30
Initiation
Apergy initiated  »

Apergy initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Feb

  • 19

    Feb

ICAGY

IAG

$0.00

(0.00%)

07:29
01/24/19
01/24
07:29
01/24/19
07:29
Hot Stocks
IAG does not intend to make offer for Norwegian Air Shuttle ASA, to sell stake »

International Airlines…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QSR

Restaurant Brands

$62.61

5.62 (9.86%)

07:28
01/24/19
01/24
07:28
01/24/19
07:28
Upgrade
Restaurant Brands rating change  »

Restaurant Brands…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

F

Ford

$8.34

-0.17 (-2.00%)

07:28
01/24/19
01/24
07:28
01/24/19
07:28
Conference/Events
Ford management to meet with Deutsche Bank »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 25

    Apr

  • 24

    Jul

  • 23

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.